At Kenvue, we learn, test, partner and optimize to bring real solutions into communities, homes and consumers’ hands. Using cutting-edge science and technology, we work diligently to earn people’s ...

Dividend Aristocrats offer consistent growth and passive income for all types of investors. Check out 4 to buy now.

These four Dividend Aristocrats are Buy-rated sector leaders with yields above 3%. Passive income investors can buy and hold ...

Kenvue has outpaced the broader market over the past year, and analysts remain cautiously optimistic about the stock’s ...

Kenvue (KVUE), the company behind Tylenol and Neutrogena, announced that Thibaut Mongon had left the company, naming Kirk Perry as interim CEO. Yahoo Finance Senior Healthcare Reporter Anjalee ...

U.S. companies are removing their CEOs at the fastest clip in two decades, data shows, as increased scrutiny from ...

Sensodyne, the toothpaste first marketed in 1961 to reduce the pain of sensitive teeth, is among premium brands on sale in pharmacies and drug stores around the world. But if you live in an Indian ...

The future of advertising is about choice, control and collaboration. Here’s how The Trade Desk is leading the charge in Canada.

Kenvue faces challenges with declining sales, cash flow risks, and high leverage. Read here for more analysis on KVUE stock.

CEO Debra Crew has stepped down after two years in the job, the world's biggest spirits maker has said, with finance chief Nik Jhangiani taking over in the interim as the company strives to boost its ...

Kenvue, which was spun off from Johnson & Johnson in 2023, has been working to shore up profitability, especially in its struggling skin health and beauty unit which includes brands like Neutrogena ...

Among the suitors are the billionaire telecom moguls Martin Bouygues and Iliad-owner Xavier Niel. Orange is also hoping for a slice of the pie, but France’s largest telecom would face significant ...